n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, June 2nd, 2016

The QualityStocks
Daily Stock List

graphic
graphic

BioSig Technologies, Inc. (BSGM)

BUYINS.NET, SeeThruEquityResearch, Stock News Now, Goldman Small Cap Research, PennyStockLocks.com, ResearchOTC, StockRockandRoll, and Wall Street Resources reported earlier on BioSig Technologies, Inc. (BSGM), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

BioSig Technologies, Inc. is a medical device company developing PURE EP™ - a proprietary technology platform designed to improve the clinical outcomes of electrophysiology (EP) procedures. The Company’s objective is to seek Food and Drug Administration (FDA) 510(k) approval for the PURE EP™ System. BioSig is preparing to commercialize the PURE EP™ System. The Company has an office in Los Angeles, California centered on research and development (R&D). BioSig Technologies is based in Minneapolis, Minnesota.

BioSig Technologies’ PURE EP™ is a next-generation surface electrocardiogram and intracardiac multichannel recording and analysis system. The design of it is to help electrophysiologists in making clinical decisions in real-time through acquiring and displaying high-fidelity cardiac signal recordings and providing guidance in identifying ablation targets (areas of tissue to treat, which otherwise create a heart rhythm disturbance or arrhythmia).

BioSig Technologies has achieved proof of concept validation through UCLA EP & Animal Labs. It is collaborating with several of the nation's most prestigious cardiac arrhythmia centers. These include Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, and the Mayo Clinic in Rochester, Minnesota. BioSig has performed pre-clinical studies at the Mayo Clinic.

BioSig Technologies has signed a Sponsored Research Agreement with The Regents of The University of California at Los Angeles (UCLA) to conduct preclinical evaluation of the Company’s PURE EP™ System in a ventricular tachycardia (VT) model. The studies will focus on intracardiac and percutaneous epicardial mapping using the PURE EP information system to explore the complex scar architecture that normally supports multiple morphologies of VT.

BioSig Technologies completed development of the PURE EP™ System prototype in 2015 to test its performance and obtain pre-clinical data. It conducted a series of pre-clinical studies at the Mayo Clinic under the leadership of Dr. Samuel Asirvatham, and many engineering studies at UCLA under the leadership of Drs. Kalyanam Shivkumar and Jason Bradfield. The main goal of these studies has been to demonstrate the clinical potential of PURE EP (not currently obtainable with contemporary recording systems).

BioSig plans to transition from pre-clinical evaluation of the PURE EP to product development. It expects to employ a 510(k) approval process and fully develop a Quality Management System. BioSig plans to submit its 510(k) medical device application to the FDA for approval to market PURE EP during the second half of this year.

This past March, BioSig Technologies announced the formation of an advanced research program with Dr. Samuel Asirvatham at the Mayo Clinic. The design of this program is to build upon the initial studies conducted at the Mayo Clinic in March, June, and November 2015 via a tripling of investment to fully characterize and develop novel features discovered during this prior preclinical work. The Company states that these features have the potential to make a major impact in the treatment of complex arrhythmias.

BioSig Technologies, Inc. (BSGM), closed Thursday's trading session at $1.80, down 0.55%, on 6,039 volume with 11 trades. The average volume for the last 60 days is 31,161 and the stock's 52-week low/high is $0.90/$2.99.

SWK Holdings Corp. (SWKH)

Zacks, Wall Street Resources, Real Pennies, and FeedBlitz reported earlier on SWK Holdings Corp. (SWKH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

SWK Holdings Corp. is a global healthcare sector focused specialty finance company listed on the OTC Markets Group’s OTCQB. The Company partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for its business partners and its investors. SWK provides novel capital solutions to a wide variety of life science companies, institutions, as well as inventors. Established in 1996, SWK Holdings is headquartered in Dallas, Texas.

SWK Holdings’ main focus is on originating and investing in structured, asset-based debt transactions in the pharmaceutical and medical device arena. This includes IP-based cash flow streams, synthetic royalties, and legacy product acquisitions.

The Company, via its subsidiary, SWK Advisors LLC, provides non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. SWK Holdings believes its financing structures realize an optimal partnership for companies, institutions, and inventors seeking capital for expansion or capital and estate planning through allowing its partners to monetize future cash flow with minimal dilution to their equity stakes.

SWK can invest at any point in the life cycle of a marketed product. This is from launch to mature, post-IP expiration. The Company’s transactions allow its counterparties to invest in higher return activities such as acquiring new technologies, financing development projects, and funding additional working capital needs. SWK’s specialty is in sub-$50 million opportunities that other structured finance investors usually regard as too small.

In May, SWK Holdings announced its Q1 2016 financial results. It reported total revenues of roughly $5.2 million for Q1, versus $5.8 million for Q1 of 2015. It also reported adjusted net income of roughly $3.1 million, or $0.24 per diluted share, for Q1, versus $3.5 million, or $0.27 per diluted share, for Q1 of 2015.

SWK reported net cash provided by operating activities of approximately $2.3 million for Q1, or $0.18 per diluted share, versus $3.4 million, or $0.26 per diluted share, for Q1 of 2015. Total income producing assets (described as finance receivables, marketable securities and investment in unconsolidated subsidiaries less non-controlling interests) were around $98.1 million as of March 31, 2016, versus $108.3 million as of December 31, 2015.

SWK Holdings Corp. (SWKH), closed Thursday's trading session at $9.80, down 2.00%, on 2,562 volume with 3 trades. The average volume for the last 60 days is 3,816 and the stock's 52-week low/high is $9.10/$45.00.

BioHiTech Global, Inc. (BHTG)

Today we are reporting on BioHiTech Global, Inc. (BHTG), here at the QualityStocks Daily Newsletter.

BioHiTech Global, Inc. is a green technology company listed on the OTC Markets Group’s OTCQB. The Company provides unique data-driven solutions for food waste disposal. It develops and deploys inventive and disruptive waste management technologies. It is a leader in zero waste solutions for businesses and municipalities of all sizes. BioHiTech Global is based in Chestnut Ridge, New York.

The Company provides waste management solutions to an international customer base covering a complete suite of technology-based disposal options capable of having a major impact on waste generation. This is while providing a true zero landfill environment. BioHiTech Global has options for on and off site biological treatment of waste.

The Company collaborated with Natural Systems Utilities recently to convert commercial food waste to energy. In addition, BioHiTech Global launched BioHiTech Cirrus, which is a new mobile application (app) for consummate insight into the waste stream.

Moreover, in Q1 2016, the Company was awarded accredited supplier designation for waste savings, by the Carbon Trust. In Q1 2016, BioHiTech Global expanded its waste stream product offering with the launch of Entsorga North America. The Entsorga North America undertaking will expand BioHiTech’s product offering towards providing disruptive, clean technology solutions, which progress the worldwide movement towards sustainability and zero waste initiatives.

Entsorga North America will manage Apple Valley Waste Conversions LLC, which is an Entsorga North America part-owned subsidiary, the company that holds an exclusive license to deploy the proprietary Entstorga HEBioT Mechanical Biological Treatment (MBT) technology across the northeastern U.S. The HEBioT MBT system converts food waste, plastics, as well as other carbon based materials from the mixed municipal solid waste (MSW) stream into an Environmental Protection Agency (EPA) recognized alternative fuel source.
 
This month, BioHiTech Global reported financial results for its Q1 ended March 31, 2016. Its Q1 2016 financial highlights in comparison to the year-ago quarter include total revenue for Q1 of 2016 increasing 64 percent to $463,000. Recurring or 'RMP' revenue for Q1 of 2016 increased 37 percent to $291,000.  Q1 2016 recurring revenue as a percentage of total revenue was 63 percent.

Q1 2016 gross profit totaled $114,000. The Company had an order backlog of 90 units at March 31, 2016. Its Q1 2016 net loss totaled $1.6 million versus a net loss of $969,000 in Q1 of 2015. For Q1 2016, BioHiTech Global set a quarterly record with 20 new Eco-Safe Digester orders from customers across the United States and globally.

BioHiTech Global, Inc. (BHTG), closed Thursday's trading session at $3.30, up 3.12%, on 1,600 volume with 7 trades. The average volume for the last 60 days is 434 and the stock's 52-week low/high is $3.15/$5.00.

Asia Equity Exchange Group, Inc. (AEEX)

Today we are reporting on Asia Equity Exchange Group, Inc. (AEEX), here at the QualityStocks Daily Newsletter.

Asia Equity Exchange Group, Inc. is a development stage company that it is working to establish and build an equity information service platform designed to provide equity investment financing information to all enterprises in the countries and regions of Asia.  Asia Equity Exchange Group’s shares trade on the OTC Bulletin Board.

The Company has its corporate headquarters in Hong Kong. It incorporated in the State of Nevada on July 15, 2013, under the name I In The Sky Inc. It changed its name as of July 22, 2015.

The Company, with its website www.asiaotcmarkets.com, invested and operated by Asian Equity Exchange Group Co., Ltd., is an intercontinental equity exchange and a service platform for companies in Asia to release equity investment and financing information. It helps companies develop in a sustainable manner. Furthermore, it introduces high-value investment markets to professional institutional and individual investors.

For this year, Asia Equity Exchange Group expects to enroll in excess of 200 qualified businesses in Mainland China, and in 10 other countries in Asia. The Company’s ultimate objective this year is to enroll 800 companies to be listed on its website for equity financing.

The Company aims to build and complement the multi-layer capital market system in Asia. It also aims to create an innovative and authoritative intercontinental equity information platform that effectively complements business functions, service means and financing channels with OTC markets in different nations and regions.

In addition, Asia Equity Exchange Group is working to build a system of international cooperation to provide listed enterprises with equity financing means via domestic and out of the country channels, and to offer nurturing, pre-listing tutoring, incubating, as well as supporting services for their listing on overseas capital markets by shifting boards.

Asia Equity Exchange Group introduces global securities and institutional investors in its shareholder structure. Moreover, it partners with international organizations in its operations. This includes investment banks, financial and legal institutions, and professional consulting teams.

Asia Equity Exchange Group, Inc. (AEEX), closed Thursday's trading session at $5.30, even for the day. The average volume for the last 60 days is 1,267 and the stock's 52-week low/high is $0.5002/$20.00.

Medicine Man Technologies, Inc. (MDCL)

CFN Media Group reported earlier on Medicine Man Technologies, Inc. (MDCL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medicine Man Technologies, Inc. represents and licenses the cultivation and dispensary Intellectual Property (IP) of Medicine Man, which is a well-respected Tier III operator in Colorado. Medicine Man Technologies provides cultivation consulting services for cannabis growing technologies and methodologies. Founded in 2014, Medicine Man Technologies is based in Denver, Colorado. The Company’s shares trade on the OTC Bulletin Board.

Furthermore, the Company engages in retail operations of cannabis products. Additionally, Medicine Man provides general business and referral management for other related service providers for its customers. It cultivates and sells by way of its parent company Medicine Man Denver, the largest cultivation/retail facility in Colorado.

Concerning cultivation technology, Medicine Man Technologies’ risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. Regarding dispensary operations, its state-of-the art dispensary model ensures patients and consumers have safe and secure access to an assortment of medical and/or recreational cannabis products.

Medicine Man Technologies works with investors, legal and licensed commercial cultivation and dispensary operators, those aiming to operate in the cannabis industry, and other support vendors. Through its pre-licensure consulting services, the Company supports an entity’s efforts within a competitive or non-competitive state application process with the goal of helping a business’s team secure a state-issued operating license.

The Company works closely with industry-leading extraction partners. These partners provide the required licensing service support and formulations to assist customers with their planned deployment of a successful processing facility. Medicine Man Technologies secured its first client/licensee in April 2014. The Company has provided guidance for over 30 licensee clients ((Colorado, Nevada, and Illinois). It currently has 24 active clients in 13 states.

This month, Medicine Man Technologies announced that it entered into licensing agreements with three Pennsylvania companies representing four counties and expects several more additions before no longer accepting clients.

Medicine Man Technologies, Inc. (MDCL), closed Thursday's trading session at $1.65, even for the day, on 500 volume with 2 trades. The average volume for the last 60 days is 4,578 and the stock's 52-week low/high is $1.36/$5.00.

graphic

The QualityStocks
Company Corner

graphic
graphic

eXp World Holdings, Inc. (EXPI)

The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $1.80, even for the day, on 41,663 volume with 31 trades. The stock’s average daily volume over the past 60 days is 12,420, and its 52-week low/high is $0.51/$1.976.

eXp World Holdings, Inc. today announced that Founder and Chief Executive Officer Glenn Sanford will be presenting at Mendix World, a two day conference in Rotterdam, Netherlands focused on strategic technology trends, digital transformation, and insight into making technology a defining characteristic of your business. Sanford will be participating in a panel discussion titled Disrupting Traditional Markets through Technology. Since 2009, eXp World Holdings, Inc. and subsidiaries have focused on leveraging technology to create efficiencies within the services industries and unprecedented opportunities for professional development and income for affiliated industry members.

eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.

Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.

Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.

Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer

eXp World Holdings, Inc. Company Blog

eXp World Holdings, Inc. News:

eXp World Holdings, Inc. CEO Invited to Speak at Mendix World

eXp World Holdings Real Estate Brokerage Division Appoints CEO and President

eXp Realty Launches in 4 More States and the District of Columbia

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $2.22, off by 1.33%, on 6,921 volume with 18 trades. The stock’s average daily volume over the past 60 days is 6,803, and its 52-week low/high is $1.25/$7.50.

International Stem Cell Corp. announced today that it has published the results of a 12-month pre-clinical, non-human primate study. The data demonstrates the safety and efficacy of the company's proprietary ISC-hpNSC® readily expandable neural stem cell derived treatment of Parkinson's disease. "The publication of the data in the peer-reviewed and highly-respected journal, Cell Transplantation, brings to conclusion the preclinical stage of ISCO's Parkinson's disease program. The data provides further evidence that parthenogenetic neural stem cells can be effective in treating the symptoms of Parkinson's disease and, along with the previously safety data, formed the basis of our application to the Australian regulatory authorities to move this program into the clinic," said Russell Kern, Ph.D., ISCO's Chief Scientific Officer.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease

International Stem Cell Corporation Announces Operating Results for the Three-Months Ended March 31, 2016

Giggles N' Hugs, Inc. (GIGL)

The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.078, up 11.43%, on 42,380 volume with 7 trades. The stock’s average daily volume over the past 60 days is 17,785, and its 52-week low/high is $0.0137/$0.25.

Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.

Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.

Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer

Giggles N' Hugs, Inc. Company Blog

Giggles N' Hugs, Inc. News:

Repeat: Giggles N Hugs to present at the 9th annual LD Micro Conference main event

Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview

Giggles N’ Hugs Signs Agreement with New York-Based Chardan Capital Markets

Monaker Group, Inc. (MKGI)

The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $3.60, up 10.69%, on 16,500 volume with 51 trades. The stock’s average daily volume over the past 60 days is 5,451, and its 52-week low/high is $1.10/$9.99.

Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.

NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.

Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.

Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.

In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.

With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.

Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer

Monaker Group, Inc. Company Blog

Monaker Group, Inc. News:

Monaker Group Shareholder Update

MissionIR Exclusive Audio Interview With Monaker Group, Inc. (MKGI) Chief Executive Officer

Monaker Group, Inc. (MKGI) Announces Engagement of DreamTeamNetwork Corporate Communications Service Suite

OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.95, even for the day, on 1,300 volume with 3 trades. The stock’s average daily volume over the past 60 days is 5,545, and its 52-week low/high is $0.60/$1.06.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

OurPet's Company Sponsors 65th Annual BetterInvesting National Convention

OurPet’s Company Reports Record 2016 First Quarter Results

Ourpet's Company Reaches a Settlement With Competitor Over Durapet(R) Patents

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

PennyPro
(GDSI)

2.

Pennybuster
(ISBG)

3.

SmallCap Network
(MBRX)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251